Menu
Currency
GWAS Study

131 genetic loci highlight immunological pathways and tissues in nasal polyposis and asthma.

Saarentaus EC, Fischer-Rasmussen K, Sliz E et al.

41213931 PubMed ID
GWAS Study Type
774567 Participants
99 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SE
Saarentaus EC
FK
Fischer-Rasmussen K
SE
Sliz E
BA
Bizaki-Vallaskangas A
LT
Laitinen T
TS
Toppila-Salmi S
KH
Kankaanranta H
KJ
Kettunen J
BK
Bønnelykke K
PA
Palotie A
MA
Mäkitie A
Chapter II

Abstract

Summary of the research findings

The coexistence of asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP) is associated with allergic phenotypes, disease severity and failure of first-line treatment for both asthma and CRSwNP. Recent studies have highlighted shared genetic components for these diseases. To better understand this shared component, we perform genome-wide meta-analyses of asthma (n = 71,481), CRSwNP (n = 9626) and chronic rhinosinusitis without nasal polyposis (CRSsNP, n = 15,448) in FinnGen and UKB (685,602 controls). We detect 131 genomic associations, including 17 novel loci for asthma, 33 novel loci for CRSwNP, and one for CRSsNP. A shared impact on asthma and CRSwNP is observed at 71 loci. A cross-trait meta-analysis using all disorders further implicates 17 loci associated with asthma or asthma and CRSwNP. We also find 17 nonsynonymous associating variants, including a novel TP63 missense variant association with CRSwNP (OR = 1.519 [1.331-1.734]). Gene set analyses confirm enrichment of genes involved with type 2 inflammation, Jak-STAT signaling, and FOXP3 signaling. Our results highlight new shared and separate genetic pathways for CRSwNP and asthma. These provide several avenues of further investigation in functional and epidemiological follow-up, and evidence for immunological and non-immunological mechanisms behind both diseases.

88,965 European ancestry cases, 685,602 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

774567
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.